Other non-specialised retail sale
PHARMASENSE AS
Revenue 2024
NOK 3.8m
Operating profit
NOK 586,000
Equity
NOK −6.3m
Incorporated
2021
Share capital
NOK 30,000
Roles
Daglig lederMaher Ayman Salameh
Regnskapsfører
Revisor
Styrets lederMaher Ayman Salameh
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| SCANDIC INV AS | 100.0% | 1000.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.